Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Transactions
Holdings
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Appointed director
CC transcript
Bonus plan approved
Inv. presentation
Acq. announced
Director departure
CUBIST PHARMACEUTICALS INC (CBST) Create: Alert

All | News | Filings
Date FiledTypeDescription
02/23/2015 SC TO-I/A Form SC TO-I/A - Tender offer statement by Issuer: [Amend]
02/17/2015 SC 13G ARISTEIA CAPITAL LLC reports a 5.8% stake in Cubist Pharmaceuticals Inc.
02/13/2015 SC 13G/A FMR LLC reports a 10.7% stake in CUBIST PHARMACEUTICALS INC
02/10/2015 SC 13G/A VANGUARD GROUP INC reports a 6.2% stake in Cubist Pharmaceuticals Inc
02/10/2015 SC 13G/A FMR LLC reports a 2.3% stake in CUBIST PHARMACEUTICALS INC
01/27/2015 SC TO-I/A Form SC TO-I/A - Tender offer statement by Issuer: [Amend]
01/22/2015 SC TO-I Form SC TO-I - Tender offer statement by Issuer:
01/22/2015 SC TO-T/A Form SC TO-T/A - Tender offer statement by Third Party: [Amend]
01/21/2015 8-K Quarterly results
01/21/2015 SC 13G/A BlackRock Inc. reports a 7.9% stake in CUBIST PHARMACEUTICALS INC
01/21/2015 SC TO-T/A Form SC TO-T/A - Tender offer statement by Third Party: [Amend]
01/15/2015 SC 13G/A BlackRock Inc. reports a 9.2% stake in CUBIST PHARMACEUTICALS INC
01/15/2015 SC TO-T/A Form SC TO-T/A - Tender offer statement by Third Party: [Amend]
01/14/2015 SC TO-T/A Form SC TO-T/A - Tender offer statement by Third Party: [Amend]
01/13/2015 8-K Other Events, Financial Statements and Exhibits
Docs: "Cubist Announces Withdrawal of Listing of CVRs from NASDAQ Global Select Market"
01/13/2015 SC TO-T/A Form SC TO-T/A - Tender offer statement by Third Party: [Amend]
01/12/2015 SC 13G/A WELLINGTON MANAGEMENT GROUP LLP reports a 3% stake in Cubist Pharmaceuticals, Inc.
01/12/2015 SC 13G/A PUTNAM INVESTMENTS LLC reports a 2.9% stake in CUBIST PHARMACEUTICALS INC
01/07/2015 SC TO-T/A Form SC TO-T/A - Tender offer statement by Third Party: [Amend]
01/02/2015 8-K Other Events, Financial Statements and Exhibits
Docs: "Failure Purchase Notice"
12/31/2014 SC TO-T/A Form SC TO-T/A - Tender offer statement by Third Party: [Amend]
12/30/2014 SC TO-T/A Form SC TO-T/A - Tender offer statement by Third Party: [Amend]
12/23/2014 SC TO-T/A Form SC TO-T/A - Tender offer statement by Third Party: [Amend]
12/22/2014 SC 13D/A Merck & Co., Inc. has filed a Schedule 13D for CUBIST PHARMACEUTICALS, INC.
12/22/2014 8-K Other Events, Financial Statements and Exhibits
Docs: "ZERBAXA addresses certain serious and resistant Gram-negative bacteria First new antibiotic approved in U.S. under the GAIN Act that treats Gram-negative bacteria"
12/19/2014 8-K Temporary Suspension of Trading Under Registrant's Employee Benefit Plans, Financial Statements and Exhibits
Docs: "Notice pursuant to Rule 104(b)(2)(i) of Regulation BTR"
12/09/2014 8-K Other Events, Financial Statements and Exhibits
Docs: "Cubist Comments on CUBICIN Patent Litigation"
12/08/2014 8-K Bonus plan approved/adopted
Docs: "Agreement and Plan of Merger, among Merck & Co., Inc., Mavec Corporation and Cubist Pharmaceuticals, Inc. Schedules to the Agreement and Plan of Merger have been omitted pursuant to Item 601(b)(2) of Regulation S-K. The registrant will furnish copies of any such schedules to the U.S. Securities and Exchange Commission upon request",
"Amended and Restated Bylaws of Cubist Pharmaceuticals, Inc. (marked)",
"Cubist Pharmaceuticals, Inc. 2014 Severance Plan and Summary Plan Description",
"Merck to Acquire Cubist Pharmaceuticals for $102 Per Share in Cash Acquisition Augments Merck's Strong Foundation and Opportunity for Growth in Hospital Acute Care Market"
11/07/2014 10-Q Quarterly Report for the period ended September 30, 2014
11/06/2014 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "Cubist Names Dr. Patrick Vink Chief Operating Officer"
10/22/2014 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "Cubist Pharmaceuticals Names Robert J. Perez Chief Executive Officer"
10/21/2014 8-K Quarterly results
Docs: "shall be deemed to be furnished, and not filed:"
08/11/2014 8-K Other Events, Financial Statements and Exhibits
Docs: "Senior Director, Corporate Communications"
08/11/2014 10-Q Quarterly Report for the period ended June 30, 2014
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy